デフォルト表紙
市場調査レポート
商品コード
1370224

臨床試験用品市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Clinical Trial Supplies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 149 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
臨床試験用品市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年10月15日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

市場概要:

世界の臨床試験用品市場規模は2022年に23億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて7.4%の成長率(CAGR)を示し、2028年には36億米ドルに達すると予測しています。

臨床試験用品とは、科学的実験や調査、臨床研究を実施するために使用される様々なツールや機器を指します。輸液ポンプ、ネブライザー、注射針は最も一般的に使用される臨床試験用品です。これらは主に、様々な病気の発見、予防、治療、治療法の効率分析、様々な感染症や代謝性疾患の診断のための医療試験を実施するために使用されます。また、呼吸器、腫瘍、心臓血管、神経学的処置の際にも幅広く使用されています。

バイオ医薬品業界の著しい成長は、市場の成長を促す重要な要因のひとつです。臨床試験は、革新的なドラッグデリバリーシステムの開発とともに、HIVやがんなどの疾患の治療において絶大な支持を得ています。さらに、コールドチェーン・ロジスティクスやモニタリング技術の開発を促進する技術の進歩も、重要な成長促進要因となっています。製品メーカーは、無駄を最小限に抑え、全体的なコスト効率を高める生産・包装プロセスの最適化に注力しています。さらに、委託研究機関(CRO)の新たな動向も市場成長にプラスの影響を与えています。CROは、製薬、バイオテクノロジー、医療機器メーカーが契約ベースで研究活動を外注することを可能にし、それによって様々な試験用品の利用を増加させる。その他にも、先進的な医薬品や治療法の開発のために政府機関や非政府組織(NGO)の両方が行っている広範な研究開発(R&D)などがあり、市場の見通しは明るいと予想されます。

本レポートで扱う主な質問

  • 世界の臨床試験用品市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
  • 業界の主要地域市場は?
  • COVID-19が世界の臨床試験用品市場に与えた影響は?
  • サービス別の市場内訳は?
  • フェーズ別の市場内訳は?
  • 治療領域別の市場内訳は?
  • 最終用途産業別の市場内訳は?
  • 業界のバリューチェーンにおける様々な段階とは?
  • 業界の主な促進要因と課題は何か?
  • 世界の臨床試験用品市場の構造と主要プレーヤーは?
  • 業界の競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 臨床試験用品の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:サービス別

  • 製品製造
    • 市場動向
    • 市場予測
  • 包装、ラベリング、保管
    • 市場動向
    • 市場予測
  • 物流・流通
    • 市場動向
    • 市場予測

第7章 市場内訳:フェーズ別

  • フェーズI
    • 市場動向
    • 市場予測
  • フェーズII
    • 市場動向
    • 市場予測
  • フェーズ III
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳:治療領域別

  • がん領域
    • 市場動向
    • 市場予測
  • 循環器疾患
    • 市場動向
    • 市場予測
  • 呼吸器疾患
    • 市場動向
    • 市場予測
  • 中枢神経系および精神疾患
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:最終用途産業別

  • 医療機器産業
    • 市場動向
    • 市場予測
  • バイオ医薬品産業
    • 市場動向
    • 市場予測
  • 医薬品産業
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Almac Group Ltd.
    • Catalent Pharma Solutions Inc.
    • DHL
    • Parexel
    • Thermo Fisher Scientific Inc.
    • PCI Services
    • Sharp Clinical
    • Biocair
    • Movianto
図表

List of Figures

  • Figure 1: Global: Clinical Trial Supplies Market: Major Drivers and Challenges
  • Figure 2: Global: Clinical Trial Supplies Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Clinical Trial Supplies Market: Breakup by Services (in %), 2022
  • Figure 4: Global: Clinical Trial Supplies Market: Breakup by Phase (in %), 2022
  • Figure 5: Global: Clinical Trial Supplies Market: Breakup by Therapeutic Area (in %), 2022
  • Figure 6: Global: Clinical Trial Supplies Market: Breakup by End-Use Industry (in %), 2022
  • Figure 7: Global: Clinical Trial Supplies Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Clinical Trial Supplies Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Clinical Trial Supplies (Product Manufacturing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Clinical Trial Supplies (Product Manufacturing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Clinical Trial Supplies (Packaging, Labeling and Storage) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Clinical Trial Supplies (Packaging, Labeling and Storage) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Clinical Trial Supplies (Logistics and Distribution) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Clinical Trial Supplies (Logistics and Distribution) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Clinical Trial Supplies (Phase I) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Clinical Trial Supplies (Phase I) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Clinical Trial Supplies (Phase II) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Clinical Trial Supplies (Phase II) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Clinical Trial Supplies (Phase III) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Clinical Trial Supplies (Phase III) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Clinical Trial Supplies (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Clinical Trial Supplies (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Clinical Trial Supplies (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Clinical Trial Supplies (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Clinical Trial Supplies (Respiratory Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Clinical Trial Supplies (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Clinical Trial Supplies (CNS and Mental Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Clinical Trial Supplies (CNS and Mental Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Clinical Trial Supplies (Medical Devices Industry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Clinical Trial Supplies (Medical Devices Industry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Clinical Trial Supplies (Biopharmaceuticals Industry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Clinical Trial Supplies (Biopharmaceuticals Industry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Clinical Trial Supplies (Pharmaceuticals Industry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Clinical Trial Supplies (Pharmaceuticals Industry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: North America: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: North America: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United States: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United States: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Canada: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Canada: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Asia Pacific: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Asia Pacific: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: China: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: China: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: India: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: India: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: South Korea: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: South Korea: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Australia: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Australia: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Indonesia: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Indonesia: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Europe: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Europe: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Germany: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Germany: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: France: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: France: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: United Kingdom: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: United Kingdom: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Italy: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Italy: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Spain: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Spain: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Russia: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Russia: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Latin America: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Latin America: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Brazil: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Brazil: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Mexico: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Mexico: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Middle East and Africa: Clinical Trial Supplies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Middle East and Africa: Clinical Trial Supplies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Global: Clinical Trial Supplies Industry: SWOT Analysis
  • Figure 90: Global: Clinical Trial Supplies Industry: Value Chain Analysis
  • Figure 91: Global: Clinical Trial Supplies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clinical Trial Supplies Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Clinical Trial Supplies Market Forecast: Breakup by Services (in Million US$), 2023-2028
  • Table 3: Global: Clinical Trial Supplies Market Forecast: Breakup by Phase (in Million US$), 2023-2028
  • Table 4: Global: Clinical Trial Supplies Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
  • Table 5: Global: Clinical Trial Supplies Market Forecast: Breakup by End-Use Industry (in Million US$), 2023-2028
  • Table 6: Global: Clinical Trial Supplies Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Clinical Trial Supplies Market: Competitive Structure
  • Table 8: Global: Clinical Trial Supplies Market: Key Players
目次
Product Code: SR112023A2104

Abstract

Market Overview:

The global clinical trial supplies market size reached US$ 2.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2028, exhibiting a growth rate (CAGR) of 7.4% during 2023-2028.

Clinical trial supplies refer to various tools and equipment that are used for conducting scientific experiments, investigations and clinical research. Infusion pumps, nebulizers and syringe needles are the most commonly used clinical trial supplies. They are primarily used for conducting medical trials for detecting, preventing and treating various ailments, analyzing the efficiency of a treatment method, and in the diagnosis of various infectious and metabolic disorders. They also find extensive applications during respiratory, oncological, cardiovascular and neurological procedures.

Significant growth in the biopharmaceutical industry is one of the key factors driving the growth of the market. Clinical trials are gaining immense traction for treating diseases, such as HIV and cancer, along with the development of innovative drug delivery systems. Furthermore, technological advancements facilitating the development of cold chain logistics and monitoring technologies, are also acting as crucial growth-inducing factors. Product manufacturers are focusing on optimizing the production and packaging processes that can minimize wastage and enhance the overall cost-efficiency. Moreover, the emerging trend of contract research organizations (CROs) is also impacting the market growth positively. CROs enable the pharmaceutical, biotechnological and medical instrument manufacturers to outsource research activities on a contractual basis, thereby increasing the utilization of various trial supplies. Other factors, including extensive research and development (R&D) undertaken by both the governmental and non-governmental organizations (NGOs) for the development of advanced drugs and treatment methods, are expected to create a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global clinical trial supplies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on services, phase, therapeutic area, and end-use industry.

Breakup by Services:

Product Manufacturing

Packaging, Labeling and Storage

Logistics and Distribution

Based on the services, the market has been segmented into product manufacturing; packaging, labeling and storage; and logistics and distribution.

Breakup by Phase:

Phase I

Phase II

Phase III

Others

On the basis of the phase, the market has been segregated into phase I, phase II, phase III and others. At present, phase III exhibits a clear dominance in the market.

Breakup by Therapeutic Area:

Oncology

Cardiovascular Diseases

Respiratory Diseases

CNS And Mental Disorders

Others

The market has been analyzed on the basis of the therapeutic area into oncology, cardiovascular diseases, respiratory diseases, central nervous system (CNS) and mental disorders, and others. Amongst these, oncology holds the largest market share.

Breakup by End-Use Industry:

Medical Device Industry

Biopharmaceuticals Industry

Pharmaceuticals Industry

Others

Based on the end-use industry, the market has been divided into medical devices, biopharmaceuticals, pharmaceuticals and others. Pharmaceuticals account for the majority of the total market share.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

On the geographical front, the market has been classified into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia and others); Latin America (Brazil, Mexico and others); and Middle East and Africa. Currently, North America enjoys the leading position in the market.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Almac Group Ltd., Catalent Pharma Solutions Inc., DHL, Parexel, Thermo Fisher Scientific Inc., PCI Services, Sharp Clinical, Biocair, Movianto, etc.

Key Questions Answered in This Report:

  • How has the global clinical trial supplies market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the industry?
  • What has been the impact of COVID-19 on the global clinical trial supplies market?
  • What is the breakup of the market based on the services?
  • What is the breakup of the market based on the phase?
  • What is the breakup of the market based on the therapeutic area?
  • What is the breakup of the market based on the end-use industry?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global clinical trial supplies market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clinical Trial Supplies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Services

  • 6.1 Product Manufacturing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Packaging, Labeling and Storage
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Logistics and Distribution
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Phase

  • 7.1 Phase I
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Phase II
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Phase III
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Therapeutic Area

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiovascular Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Respiratory Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 CNS and Mental Disorders
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-Use Industry

  • 9.1 Medical Device Industry
    • 9.1.1 Market Trends
    • 9.1.3 Market Forecast
  • 9.2 Biopharmaceuticals Industry
    • 9.2.1 Market Trends
    • 9.2.3 Market Forecast
  • 9.3 Pharmaceuticals Industry
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.3 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Almac Group Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Catalent Pharma Solutions Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 DHL
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Parexel
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Thermo Fisher Scientific Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 PCI Services
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Sharp Clinical
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Biocair
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Movianto
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio